Pfizer vaccine News

During the Corona transition period, India was trying that foreign companies should also make vaccines in India so that the people of India could get the vaccine. Today in DNA, know why the Government of India did not buy the vaccine from abroad!

The sole reason was unjustified demands by foreign corporations. Moderna and Pfizer merely saw India as a huge market and were confident that India, with its massive population, would not be able to tide over the crisis without their help.

Pfizer has said that its COVID-19 vaccine provided strong long-term protection against the virus The study has been conducted among adolescents aged 12 to 15 years A two-dose series of the vaccine was 100% effective against COVID-19, the company said

Some people may have antibodies just as powerful as 2C08 protecting them against SARS-CoV-2 There is no evidence that Delta variant is better at overcoming vaccine-induced immunity compared to other variants

India is in talks to buy 50 million doses of Pfizer vaccine The US drugmaker has not yet sought permission for use of its COVID-19 vaccine in India.

Pfizer said on Tuesday that it will begin testing its COVID-19 vaccine on a large group of children under the age of 12 after selecting a low dose of the shot in the first phase of testing. 4,500 children have been enrolled in 90 locations in some countries for the trial.

WHO has classified the coronavirus variant first found in India as a "variant of global concern" They also said studies show the B.1.617 mutation spreads more easily than other variants

25 bed CCC hospital is opened at Gurudwara Shri Manji Sahib, Alamgir, Ludhiana Covid 19 patients are provided preliminary medical aid and medicines as well as oxygen in these facilities These facilities are in addition to an already running dedicated 100-bed hospital for the treatment of Covid-19 patients at Sri Guru Ramdas Charitable Hospital, Amritsar

Pfizer to seek FDA emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September Pfizer is already expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old

The US company, which was the first drugmaker to apply for emergency use authorization of its COVID-19 vaccine in India, had a meeting with the country`s drugs regulator on Wednesday and the decision was made after that, the company said.

Norway has launched a probe into the death of two nursing home residents. The two died after receiving COVID-19 vaccine developed by Pfizer and BioNTech. It comes after a paediatric surgery assistant in Portugal died two days after receiving Pfizer's vaccine.

Sonia Acevedo, a 41-year-old nurse suffered a "sudden death", 48 hours after being vaccinated with Pfizer-BioNTech vaccine. She had no health condition before and did not suffer from any side effects after taking the vaccine. Sonia worked at the Portuguese Institute of Oncology in the department of paediatrics in Porto.

The European Union will start mass vaccinations against COVID-19 after Christmas as the shot developed by Pfizer and its German partner BioNTech cleared regulatory hurdles The European Union plan to start vaccinations from Sunday (December 27) EMA, EC gave final approval to the EU`s first COVID-19 vaccine.

US head nurse faints during a press briefing. She was given a COVID vaccine shot hours back. The nurse said she has a history of fainting incidents.

US added a second COVID-19 vaccine to its arsenal Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. And the National Institutes of Health. The move marks the world's first authorization for Moderna's shots.

US Vice President Mike Pence will be receiving COVID-19 vaccine publicly Mike Pence, his wife Karen Pence and Surgeon General Jerome Adams will all receive the vaccine for COVID-19 at the White House. Acting Secretary of Defense Chris Miller received the vaccine produced by Pfizer and BioNTech publicly earlier this week

Johnson confirmed that the first phase of the vaccine deployment will include care home residents, health and care staff, the elderly and those who are clinically extremely vulnerable His address came hours after the UK govt confirmed that it has authorised the use of Pfizer/BioNTech to immunise against COVID-19 The MHRA will decide what additional quality assurance checks may be required before a vaccine can be made available

The extreme low temperature required for storing Pfizer's COVID-19 vaccine poses a challenge for its delivery in India. AIIMS Director Dr Randeep Guleria said maintaining such cold chain facilities would be very difficult in India.